Denise L. Blomquist - 28 Jul 2025 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: Chief Accounting Officer
Issuer ticker: MDT
Reported as of: 28 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Jul 2025, 16:15:13 UTC
Prior SEC filing: 04 Jun 2025
Next SEC filing: 04 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Denise L. Blomquist filed Form 4 for Medtronic plc (MDT) on 30 Jul 2025.

Key facts

This page summarizes Denise L. Blomquist's Form 4 filing for Medtronic plc (MDT).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 30 Jul 2025, 16:15.

Change

Previous filing in this sequence was filed on 04 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002061393 Primary reporting owner

Blomquist Denise L.

Relationship: Chief Accounting Officer
Address: 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 30 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +2,202
Change %: +22%
Price: $0.000000
Shares after: 12,425
Date: 28 Jul 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Units

Award

Transaction value: $0
Shares: +2,202
Change %
Price: $0.000000
Shares after: 2,202
Date: 28 Jul 2025
Ownership: Direct
Underlying class: Performance Share Unit
Underlying amount: 2,202
Exercise price
Footnotes: F3, F4, F5

MDT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +1,278
Change %
Price: $0.000000
Shares after: 1,278
Date: 28 Jul 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,278
Exercise price: $91.97
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Footnote F2

Includes 52 shares acquired through dividend reinvestment and 28 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

Footnote F3

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F4

Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.

Footnote F5

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,202 shares will be issued. If maximum performance metrics are achieved, 4,404 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Footnote F6

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.